Document Detail

The role of intracoronary thrombolysis and percutaneous transluminal coronary angioplasty in evolving myocardial infarction.
MedLine Citation:
PMID:  2935256     Owner:  NLM     Status:  MEDLINE    
Early reperfusion and interruption of the evolution of myocardial ischemia to necrosis can dramatically reduce the extent of myocardial damage and favorably influence the outcome of acute myocardial infarction. Intracoronary thrombolysis and percutaneous transluminal coronary angioplasty, alone or in combination, are an effective method of nonsurgical revascularization in selected patients. Potential applications of these methods, their advantages and disadvantages, and current available experience are discussed.
G DiSciascio; M J Cowley
Related Documents :
19465626 - Paramedic-led prehospital thrombolysis is safe and effective: the east anglian experience.
9710686 - Hbw 023 (recombinant hirudin) for the acceleration of thrombolysis and prevention of co...
16888266 - Tandem internal carotid artery/middle cerebral artery occlusion: an independent predict...
9114756 - Removal of thrombus from aortocoronary bypass grafts and coronary arteries using the 6f...
8450596 - The body surface qrst isointegral maps in infants with right ventricular overload.
1505656 - Factor viii and coronary heart disease.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cardiology clinics     Volume:  3     ISSN:  0733-8651     ISO Abbreviation:  Cardiol Clin     Publication Date:  1985 Feb 
Date Detail:
Created Date:  1986-03-12     Completed Date:  1986-03-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8300331     Medline TA:  Cardiol Clin     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  73-83     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Balloon*
Combined Modality Therapy
Coronary Angiography
Coronary Disease / complications,  surgery
Evaluation Studies as Topic
Fibrinolytic Agents / therapeutic use*
Myocardial Infarction / drug therapy,  surgery,  therapy*
Streptokinase / administration & dosage,  therapeutic use
Reg. No./Substance:
0/Fibrinolytic Agents; EC 3.4.-/Streptokinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Complex coronary angioplasty in patients with prior coronary artery bypass surgery, in situations ut...
Next Document:  The cell surface of a restrictive fenestrated endothelium. II. Dynamics of cationic ferritin binding...